Sex-driven vulnerability in stress and drug abuse by Berry, Alessandra et al.
M
o
n
o
g
r
a
p
h
ic
 s
e
c
t
io
n
167
Sex-driven vulnerability in stress 
and drug abuse
Alessandra Berry, Carla Raggi, Marta Borgi and Francesca Cirulli 
Dipartimento di Biologia Cellulare e Neuroscienze, Istituto Superiore di Sanità, Rome, Italy
Ann Ist Super Sanità 2016 | Vol. 52, No. 2: 167-175
DOI: 10.4415/ANN_16_02_07
“For some traits… the presence or absence of sex differ-
ences is sufficiently robust that randomly cycling females can 
be studied without additional variability being introduced 
by the estrous cycle” [1]
INTRODUCTION
Understanding the significance of sex differences is 
becoming a priority not only in clinical research but 
also in basic science. More than twenty years ago, the 
US National Institutes of Health (NIH) acknowledged 
that gender imbalance in clinical research could have 
been harmful for women’s health, as well as for sci-
ence, and began requiring women (and minorities) to 
be included in NIH-funded clinical research. Currently, 
approximately half of the patients enrolled in (NIH-
funded) clinical trials are women [2]. Despite this suc-
cessful policy, basic science still lags behind [2]. For this 
reason, starting from January 2016, the US NIH has 
implemented a policy that expects scientists to take into 
account sex as a biological variable also in preclinical 
research [3]. In addition, EU-funded research is also 
required to add a “gender dimension” under the Ho-
rizon 2020 Program (see Guidance in gender equality 
in Horizon 2020, http://ec.europa.eu/research/partici-
pants/data/ref/h2020/grants_manual/hi/gender/h2020-
hi-guide-gender_en.pdf).
Differences between sexes can be found throughout 
life (in both animal models and human studies) and 
may account for genetic, epigenetic and environmental/
hormonal factors. In addition, they might be observed 
at very different levels, ranging from organismal and 
systemic to cellular and molecular mechanisms [4]. In 
this context, individual features (genetic background) 
and environmental factors (stressful life events) can 
interact providing the ground for sex-driven liability to 
non-communicable pathologies, including “substance-
related and addictive disorders” (as defined in the 
DSM-V [5]). 
Epidemiological data, widely supported by preclinical 
research, provide strong evidence for stress being a risk 
factor for the onset and/or precipitation of many dif-
ferent pathological conditions. Stress is perceived and 
elaborated differently from male and female subjects 
and coping strategies towards stress are clearly sex-
driven. These differences in stress responses emerge as 
the result of organizational and activational effects of 
gonadal hormones as well as of genes on the sex chro-
mosomes [6]. The activation of the neuroendocrine 
system, particularly the hypothalamic-pituitary-adrenal 
(HPA) axis, as a result of stress or arousing stimuli, 
plays also a pivotal role in the neuro-behavioural and 
psycho-biological processes underlying (the different 
stages characterizing) drug addiction [1, 7-9]. Sex dif-
ferences in rates of substance abuse are consistently ob-
served in the general population with regards to rates 
of substance use, abuse, and dependence. In humans, 
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Abstract
A growing body of literature shows that a link exists between substance abuse and stress 
and that the crosstalk of sex hormones with the neuroendocrine system might differently 
prime vulnerability to drug addiction in male and female subjects. Thus, understanding 
the neurobiological mechanisms of addiction and the identification of sex-driven deter-
minants in vulnerability to drug abuse may help to better devise and/or implement stra-
tegic (pharmacological, behavioural, social) interventions to prevent or face the issue of 
addiction. Differences between sexes can be found at all stages of life (in both the animal 
model and human studies) and may account for genetic, epigenetic and environmental/
hormonal factors that in turn affect the functionality of the whole organism leading also 
to a sex-driven differential vulnerability or resilience to non-communicable pathologies. 
These include the onset and precipitation of stress-related psychiatric disorders as well 
as “substance-related and addictive disorders” (as defined in the DSM-V). This paper 
reviews the scientific literature highlighting significant differences in male and female 
subjects in stress and neuroendocrine function and the implications for sex-dependent 
differential vulnerability to drug addiction. 
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men show more drug and alcohol consumption and 
show higher degree of misuse. By contrast, data ob-
tained from animal studies provide evidence for female 
sex being overall more vulnerable [1]. Thus, the use of 
both sexes in animal model might unveil sex differences 
in the neurobiological mechanisms regardless of cultur-
al factors specific to humans.
A WORKING DEFINITION OF STRESS, 
HOMEOSTASIS, ALLOSTASIS  
AND ALLOSTATIC LOAD
Stress is any change of the internal or external milieu 
affecting the homeostasis. In complex organisms, the 
central nervous system plays a pivotal role in the stress 
perception and interpretation by determining what is 
threatening and potentially harmful [10]. As a conse-
quence, the brain and the body trigger a coordinated 
set of intercellular signals, physiological as well as be-
havioural responses leading to individual (sex-specific) 
strategies to cope with stress. This stress-driven physi-
ological set point, in the short run, is pivotal to face the 
real or perceived stressor and to maintain homeostasis. 
However, if stress becomes chronic it can trigger dis-
eases’ onset and/or accelerate their progression (includ-
ing psychiatric disorders) or promote risky changes into 
lifestyle that might easily precipitate into pathological 
life-threatening habits (e.g. alcohol or drug users might 
develop drug addiction) [7]. Thus, stress represents a 
main risk factor for mental health and comorbid patho-
logical conditions including drug addiction. 
A very simplified model of how stress is perceived 
by an organism, elaborated and translated into (more 
or less efficient physiological and behavioural) coping 
strategies involves the activation of the HPA axis. More 
in detail, hypothalamic corticotropin-releasing fac-
tor (CRF) neurons within the paraventricular nucleus 
(PVN) release CRF into the hypophyseal portal circula-
tion leading to the release of adrenocorticotropic hor-
mone (ACTH) into the general circulation, eventually 
leading to the synthesis and release of the glucocorticoid 
hormones (GC – cortisol in humans and corticosterone 
in rodents) from the adrenal gland cortex. The prima-
ry function of GC is to make energy storage available 
(catabolic action) to increase fuel in order to promote 
survival abilities of an organism during stress. However, 
under basal conditions, they coordinate daily activities 
and sleep-related events through circadian (and ultra-
dian) secretory bursts [11, 12]. The action of GC hor-
mones on central and peripheral targets is mediated by 
mineralocorticoid receptors (MR) and glucocorticoid 
receptors (GR). In the brain, both these receptors are 
widely expressed in the limbic system (including hip-
pocampus, hypothalamus and pituitary, lateral septum 
and amygdala) a brain circuit involved in the modula-
tion of emotions and cognition and in the elaboration 
of stress-related behavioural responses. In addition, GR 
and MR are also highly expressed in the pre-frontal cor-
tex, a brain region involved in the inhibitory as well as in 
the emotional control of behaviour [13-16]. 
Responsible for much of the effects of basal and low-
stress levels of GC at the onset of the stressor (i.e. the 
permissive effects) are MR, whereas GR largely medi-
ates the effects of high-stress levels of GC, facilitating 
the re-establishment of homeostasis (negative feed-
back) when GC stress levels prevail [8, 14, 17]. These 
receptors are also involved in the feedback mechanisms 
that tightly regulate GC secretion and the functionality 
of the HPA axis, preventing the axis from the delete-
rious effects of its overshooting. In fact, alterations in 
the effectiveness of negative feedback by GC have pro-
found implications for the activity of the HPA axis and 
regulation of stress responses, such that aberrant action 
can increase the vulnerability of the individual to stress-
induced disorders or diseases [14]. 
During chronic stressful conditions, prolonged acti-
vation of the HPA axis and the consequent hyper-expo-
sure to GC hormones might lead to a syndromal state 
that in 1936 Selye described as the “general adaptation 
syndrome” [18]. Thus, GC have both protective and 
damaging effects on the brain and the body. In the short 
run they are essential for adaptation, maintenance of 
homeostasis, and survival (allostasis = maintaining sta-
bility through changes). Yet, over longer time intervals, 
they impose a cost (allostatic load) that can accelerate 
disease processes or participate to pathological changes 
that may include – among many others – the onset and 
precipitation of different psychiatric conditions and 
even promote addictive processes [7, 8, 19-22]. 
SEX-DEPENDENT VULNERABILITY  
TO STRESS
Epidemiological data provide strong evidence for 
stress being a risk factor for the onset and/or precipita-
tion of many different pathologies. To this regard, many 
psychiatric disorders are accompanied by a hyper- or 
hypo-activity of the HPA axis, as well as by disturbances 
in the temporal pattern of GC secretion [14, 17]. Worth 
noticing, as also reported by the WHO (www.who.int/
mental_health/prevention/genderwomen/en/), the over-
all rates of psychiatric disorders are almost identical 
for men and women. However, prominent sex differ-
ences exist in different psychiatric pathologies. As an 
example, the incidence of major depressive disorder is 
almost two-fold greater in women than in men [23, 24]. 
Thus, investigating sex-specific mechanisms underlying 
mental health, as well as sex-dependent determinants of 
resilience/vulnerability to stress, should be a priority for 
clinical and preclinical science.
Efficient (physiological and behavioural) coping 
strategies involve the activation of a tightly regulated 
set of signalling pathways where sex differences can 
be found at all levels. Male and female subjects show 
substantial differences within the HPA axis physiology 
that include different aspects ranging from its function, 
organization and morphology (see also [25] and refer-
ences therein). Studies dating back to the ’60s already 
reported differences in the basal activity of the HPA 
axis with female rats (holding mature ovaries) showing 
a facilitation in the diurnal excursions of corticosterone 
levels due to circadian rhythm [26]. Successively Kant 
et al. provided evidence for plasma corticosterone lev-
els showing a faster increase in females than in males 
rats following stressors of different nature [27]. This is 
mainly due to a suppression of the HPA axis in males by 
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activational testosterone after puberty. At a molecular 
level, studies have provided evidence for gonadal hor-
mones affecting sex differences in stress responsivity 
through the modulation of neurotransmitter systems 
including serotonin (5-HT) norepinephrine and CRF 
receptor expression and internalization. In addition, 
behavioural sex-differences have been observed in re-
sponse to stress with female subjects being character-
ized by more passive coping strategies (e.g. increased 
immobility in the forced-swim and tail-suspension tests 
compared to males) (see [6, 25] and references therein 
for complete reviews). 
Adult response to stress are the result of the indi-
vidual genetic asset and the pre- and/or post-natal 
environment. Thus, stressful events experienced dur-
ing prenatal life and the early postnatal periods until 
adolescence might profoundly impact the developing 
systems leading to a life-long vulnerability to diseases 
[28, 29]. Patchev and colleagues first described how the 
gonadal hormones might shape the development of the 
HPA axis leading to a male or female neuroendocrine 
phenotype. More in detail, they provide evidence that 
the exposure to the hormonal milieu is tightly regulat-
ed leading to a sex-driven expression of glucocorticoid 
receptors (MR and GR) as well as of CRF within the 
PVN [30]. A great body of evidence has clearly shown 
that exposure to stressful experiences during sensitive 
ontogenetic phases might greatly affect the final out-
come of developmental trajectories possibly leading 
to a mismatch between the gonadal sex and brain sex 
[28, 29]. This, might in turn disrupt the sexually dimor-
phic brain, eventually changing sex-driven responses to 
stress and coping strategies, leading to sex-driven risk in 
disease onset [6]. 
Studies on animal models of prenatal stress have 
clearly shown that HPA axis alterations may vary ac-
cording to gender and to the nature or the intensity of 
the stressor, setting the stage for a life-long vulnerability 
[29, 31-38]. A hyperdrive of the HPA axis is observed 
in both male and female rats exposed to prenatal stress 
and this is associated to increased behavioral responses 
in both sexes as a result of exposure to novel stimuli and 
to increased anxiety-like behavior only in adult males (re-
viewed in [29, 38]). Very recently, Luoni et al. found that 
exposure to prenatal restrain stress produces significant 
changes in BDNF expression, a neurotrophin acting as 
a neuroendocrine effector leading to plastic changes in 
response to stress. This, results in a selective reduction in 
the hippocampus of female rats. Moreover, female sub-
jects showed a reduced ability to cope with acute stress 
at adulthood [37]. Interestingly, exposure to prenatal 
stress might lead also to a selective sex-dependent vul-
nerability to drug addiction. To this regard, Thomas et al. 
found that, under basal conditions, female rats showed 
a greater ability to acquire cocaine self-administration 
within a certain number of test sessions when compared 
to males. By contrast, prenatal stress led to a significant 
increase in the proportion of male offspring reaching the 
criterion and this was comparable to that of females. 
Furthermore, these authors provide also evidence for 
prenatal stress resulting in sex-specific risk factor for dif-
ferent aspects of substance abuse [39]. 
Differently from early ontogenetic phases, adoles-
cence is a critical time characterized by a strong rear-
rangement of neurochemical systems underlying brain 
excitability. During this time, organisms are still vulner-
able to stress but, at the same time, they are already 
able to respond to it. During adolescence, the neuro-
endocrine system undergoes a main rearrangement to-
wards the adult phenotype and this is often paralleled 
by main changes in the sexual hormones levels leading 
to the onset of puberty [40]. Significant modifications 
in the psychosocial behavioural patterns occur during 
this time that also include an increase in novelty seek-
ing, possibly priming the initiation to drug use/abuse 
(see later). Likewise, in humans, adolescence might re-
sults in a critical temporal window for the emergence of 
psychopathology. However, given the prominent plas-
ticity characterizing this time, it could also represent 
an important critical time for early intervention [41]. 
Studies in rodents have shown that new cells are added 
to the hypothalamus and amygdala in a sex-specific 
manner during puberty and gonadectomy before reach-
ing sexual maturity prevents this effect [42]. These sex-
driven differences in the number of newly added cells 
are paralleled by similar differences in adult brain vol-
umes, suggesting that the changes programmed during 
puberty are long lasting [6]. 
Overall, the mechanisms by which sex differences in 
stress responsivity emerge and promote sex-driven dis-
ease risk (including substance-related and addictive dis-
orders) are very complex and might rely upon a dynamic 
crosstalk between environmental factors and dynamic 
fluctuation of sexual hormones throughout pre- and 
post-natal development (see Figure 1). As recently re-
viewed by Bale and Epperson [6], animal models and 
human studies suggest that male subjects might be at 
greater risk for behavioural or neurodevelopmental dis-
orders (e.g. schizophrenia, autism spectrum disorder 
and attention deficit hyperactivity disorder) in associa-
tion with prenatal stress. By contrast, females might be 
more vulnerable to the onset of affective disorders (e.g. 
depression) as the result of stressful experiences occur-
ring during early post-natal and peri-pubertal phases [6].
MECHANISMS AND SUBSTRATES  
OF STRESS-RELATED VULNERABILITY  
TO DRUG ADDICTION
Drug use and drug abuse are distinct phenomena 
and, in humans, most drug users will never develop ad-
diction [7]. Clinical and animal experimental studies 
have shown that a clear distinction can be done between 
“vulnerable” and “resistant” individuals, the former 
showing a prominent aptitude towards drug addiction 
[8]. Epidemiological and preclinical data have provided 
evidence that the activation of neuroendocrine system 
upon stress and its crosstalk with sex hormones might 
differently prime vulnerability to drug addiction in male 
and female subjects [2, 43-45]. Thus, understanding the 
neurobiological mechanisms of addiction and identify-
ing individual and sex-driven determinants in vulner-
ability to drug abuse has become a main target in this 
field of research [1, 8]. In this context, the role played 
by environmental and socio-economic factors should 
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be also carefully considered as a main interactor with 
individual features setting the ground for vulnerability.
The concept of sensation seeking, as originally de-
fined by Zuckerman [46], refers to “the need for varied, 
novel, and complex sensations and experiences and the 
willingness to take physical and social risks for the sake 
of such experience” and has been considered as a en-
dophenotype of drug addiction [47, 48]. Epidemiologi-
cal data and studies performed on animal models have 
shown that certain individuals actively seek for stimuli 
or situations characterized by arousing/stressful fea-
tures (sensation seekers) that lead to the activation of 
the HPA axis and consequently to the secretion of GC 
hormones. Sensation seeking – in humans – is a per-
sonality trait characterized by a defined developmental 
pattern showing a peak at adolescence and declining 
with age (inverted “U” shape). During adolescence, the 
brain and the neuroendocrine system undergo a main 
rearrangement towards the adult phenotype and this is 
often – though not always – paralleled by main changes 
in the sexual hormones milieu leading to the onset of 
puberty. Significant modifications in the psychosocial 
behavioural patterns occur during this time that also in-
clude an increase in the novelty seeking [46]; as an obvi-
ous consequence adolescence is a critical age very prone 
to the initiation of nicotine, alcohol and recreational 
drug consumption [40] or to pathological gambling [49, 
50]. Interestingly, the presence of personality traits (in 
healthy adults), such as sensation seeking, have been 
related with changes in the HPA axis function [51]. 
More in detail, high degree of disinhibition and novelty 
seeking consistently show an inverse relationship with 
cortisol levels across studies (also assessed by means 
of the dexamethasone/CRH suppression test) [51-54] 
with young males showing a stronger association than 
females [55]. Thus, it is possible to hypothesize that in-
dividuals showing reckless and risky behaviours might 
be characterized by higher threshold for physiological 
arousal [51]. Accordingly, low salivary cortisol levels 
have been observed in children with oppositional be-
haviour and conduct disorder [56-58] suggesting that 
some behavioural traits might share common neurobio-
logical mechanisms.
As for the mechanisms, animal models have greatly 
contributed to unveil the neurobiological and behav-
ioural correlates underlying the influence of stress on 
drug addiction. In fact, laboratory conditions allow 
controlling for the “history” and the “experiences” of 
each subject (that can be manipulated on purpose); 
moreover, they allow reliable measure of the outcome 
of stress on drug abuse since all individuals have an 
equal access to drugs under identical environmental 
conditions [9]. Studies dating back to almost forty 
years ago showed that electric shock might hold posi-
tive reinforcing properties in squirrel monkeys leading 
to self-stimulation upon lever pressure. In rats, intense 
handling (a mild form of stress) may induce place pref-
erence - a behaviour often observed during experimen-
tal protocols of drug addiction - while certain individu-
als self-stimulate aversive brain regions resulting in a 
behavioural and autonomic profile comparable to that 
observed in conditions of physiological stress [59-61]. 
In this context, Piazza et al., in a seminal work, provided 
insights into the physiological role of GC in the biology 
of sensation seeking and the mechanisms relating in-
dividual susceptibility to (psychostimulant) drug addic-
tion [62]. In fact, they showed that the activation of the 
HPA axis and the consequent GC secretion underlies 
the appetitive properties of stressful and stimulating ex-
perience and that in vulnerable subjects (HR rats) they 
may potentiate the reinforcing properties of drugs of 
abuse. Thus, the higher sensitivity of certain individuals 
to the reinforcing effects of GC (secreted during stress-
ful events) might be a biological basis of the phenom-
enon described as sensation seeking, setting the ground 
for vulnerability to drug addiction [62]. Dopaminergic 
neurons in the mesocorticolimbic system are the main 
substrate for the rewarding effects of different drugs of 
Figure 1
Stress experienced during early life phases (pre- and/or post-natal life) might prime the developing HPA axis setting the stage for 
long-term vulnerability. A second stressful hit in combination with puberty-induced burst of sexual hormones might lead to sex-
biased vulnerability to drug addiction onset and or/relapse. 
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abuse and are characterized by elevated expression of 
GR [63]. A number of studies using transgenic models 
have further shed light on the role played by GC and 
GR in the mechanisms underlying vulnerability to drug 
addiction. Deroche-Gamonet and colleagues showed 
that disruption of the GR gene in the central nervous 
system results in decreased motivation to cocaine self-
administration and in a suppressed psychomotor sensi-
tization [64]. In addition, they further provide evidence 
for GR being specifically involved in the modulation of 
cocaine-induced reinforcing effects [65]. Interestingly, 
Saal et al. [66] provided evidence for GC mediating the 
stress-induced changes in synaptic plasticity similar to 
those observed following cocaine self-administration 
within the dopaminergic reward circuit (see also the re-
view by [67]). Thus, it is possible that GC may prime 
the brain reward circuit for the subsequent actions of 
drugs of abuse; this might be achieved by triggering cru-
cial synaptic changes acting synergistically with drugs of 
abuse [8].
“STRESSING” SEX DIFFERENCES  
IN VULNERABILITY TO DRUG ADDICTION: 
FOCUS ON ANIMAL MODELS
Preclinical research is providing ever-increasing evi-
dence for sex differences being found at very different 
levels, ranging from systemic to cellular and molecular 
mechanisms of target models [4]. Therefore, it is not 
surprising that sex differences can be found in vulner-
ability to drug addiction. Such sex-dependent differenc-
es, in human subjects, are enriched through the course 
of life by cultural aspects, leading to the observed gen-
der-dependent differences in behaviour and habits [68]. 
Drug addiction can be viewed as a progressive he-
donic-homeostatic dysregulation eventually leading to 
main allostatic changes in the brain reward and stress 
systems and can be defined by the stages through which 
users progress: 1) binge/intoxication; 2) withdrawal/
negative affect; and 3) preoccupation/anticipation [1, 
7]. Studies on animal models taking into account all 
these phases have provided evidence for female sub-
jects (mostly rats) being overall more vulnerable than 
males; this finding is even more intriguing if considering 
that drugs of abuse are not identical with regard to their 
impact on the addiction cycle. More in detail, female 
rats show a faster learning of drugs self-administration 
as well as a faster dose escalation in addition to a great-
er motivational withdrawal. Moreover, animal models 
specifically focusing on “craving” (stage 3 of addiction) 
have provided evidence for a more prominent relapse in 
female subjects. The groundwork for such differences 
might rely both on sex specific organizational effects 
(taking place mainly during development, e.g. neonatal 
rats treated with estradiol show the male phenotype), 
and activational effects of gonadal hormones (e.g. adult 
female subjects undergoing ovariectomy are mostly 
comparable to the male phenotype) [30, 69]. In this re-
gard, brain regions such as the dorsal striatum, prefron-
tal cortex, nucleus accumbens, and medial extended 
amygdala, that play pivotal roles in the different stages 
of drug addiction, show a prominent sexual dimorphism 
and contain gonadal hormone receptors possibly being 
involved in mediating, at least in part, sex-dependent 
vulnerability to drug addiction [70].
A different, complementary and more subtle way for 
gonadal hormones to set the ground for sex-dependent 
vulnerability to drug addiction is through a differential 
activation of the HPA axis in male and female subjects 
upon stress. Male and female rodents are characterized 
by different stress responses that are mediated both by 
adult levels of gonadal hormones as well as by develop-
mental programming of the HPA axis [25]. The par-
ticipation/activation of the neuroendocrine system, and 
particularly of the HPA axis, has been observed, to a 
greater or lesser extent, in almost all stages of drug ad-
diction [1, 7]. As an example, Torres et al. have recently 
reported that stress triggers the initiation of nicotine in-
take in female rats [71] that also show increased corti-
costerone and ACTH levels during nicotine withdrawal 
[71, 72]. There is evidence for female subjects to show 
enhanced drug-, cue-, and stress-induced reinstatement 
in animal models of alcohol and drug seeking [73, 74]. 
This latter piece of data is consistently observed across 
different species and might resemble the persistent pre-
occupation/anticipation (craving) stage of the addiction 
cycle [1]. 
When compared to males, female subjects show high-
er basal and stress-induced GC secretion and a higher 
stress response in the hypothalamic PVN (see [25] and 
references therein for a detailed review). Moreover, 
estradiol can enhance the stress response during the 
estrous cycle in rats and monkeys, while progesterone 
exert an opposite effect [1]. Thus, sex differences in the 
stress response may well participate in the observed dif-
ferent sex-dependent vulnerability to drug addiction.
Very recently, Becker and Koob have dedicated an 
extensive review to the neurobiological basis of sex dif-
ferences in preclinical animal models of drug abuse [1]. 
Worth to notice, these authors use the framework of 
drug addiction to highlight the importance of taking 
into account sex differences in basic science address-
ing the fact that there is still an unmet need to improve 
experimental designs by the inclusion of both sexes in 
preclinical research [2]. In particular, animal models (of 
drug addiction) should distinguish four main research 
domains i.e. 1) qualitative, 2) quantitative, 3) popula-
tion, and 4) mechanistic. “Qualitative differences” are 
represented by apparent sexually dimorphic traits. 
“Quantitative differences” rely on the magnitude of the 
response (e.g. female rats show a higher locomotion 
following psychostimulant drugs administration and 
a greater behavioural sensitization when compared to 
males [75]). Sex differences in the incidence or distri-
bution of individual traits are referred to as “popula-
tion differences”. As an example, Perry et al. were able 
to identify a subpopulation of female rats more prone 
to drug addiction than males though the behaviours 
showed during cocaine consumption were the same for 
males and females [76]. Within this domain (“popula-
tion differences”) the environment (e.g. stressful experi-
ences) may play a prominent role. In fact, it may shape 
individual developmental trajectories in a sex-driven 
direction and this may in turn affect the distribution 
of a certain trait, including vulnerability to drug addic-
Alessandra Berry, Carla Raggi, Marta Borgi and Francesca Cirulli
M
o
n
o
g
r
a
p
h
ic
 s
e
c
t
io
n
172
tion, within a population [37, 77, 78]. To this regard, 
Thomas et al. found that under basal conditions female 
rats showed a greater ability to acquire cocaine self-
administration within a certain number of test sessions 
(three) when compared to males. By contrast, prenatal 
stress led to a significant increase in the proportion of 
male offspring reaching the criterion and this was com-
parable to that of females thus resulting in a change in 
the distribution of the population [39]. As for the last 
domain (mechanism), a trait that may look alike for fe-
male and male subjects might be mediated by different 
sex-dependent neural/molecular mechanisms. A promi-
nent example for this domain is provided by the CRF 
receptor 1 (CRFR1). This receptor is a primary ligand 
for CRF that is secreted from the hypothalamus and ini-
tiates the signalling cascade triggering HPA axis activa-
tion upon stress but also under conditions of acute drug 
withdrawal [79, 80]. Corticotropin-releasing-factor re-
ceptor 1 is expressed in different brain regions, playing 
a main role in the reward and reinforcement properties 
as well as in the craving and aversive effects of drugs 
of abuse [81]. In this context, it is interesting to note 
that there is evidence for sex-driven differential activa-
tion in CRFR1 coupling to G-proteins and β-arrestin, 
that might lead to an increased vulnerability of females 
to the effects of acute stress and a reduced capacity to 
cope with chronic stress [82]. Likewise, sex differences 
in CRFR1 deficient mice have been reported follow-
ing morphine withdrawal in a paradigm of conditioned 
place aversion [80]. It is interesting to note that at least 
in three of the four domains taken into account by 
Becker and Koob differences in systems and pathways 
mediating stress response appear to play a main role.
Sex differences in rates of substance abuse are consis-
tently observed in the general population with regards 
to rates of substance use, abuse, and dependence. In 
humans, men show more drug and alcohol consump-
tion and show higher degree of misuse. However, the 
abuse of drugs in women is quickly approaching that of 
men suggesting that the distance between females’ and 
males’ “cultural niches”, that greatly contribute to shape 
human behaviour and human (cultural) habits, are pro-
gressively reducing. In this context, the use of both sexes 
in animal model hold the great potential to unveil sex 
differences in the neurobiological mechanisms regard-
less of cultural factors. As stated by Becker and Koob, 
“A better understanding of the ways males and females 
can differ will help scientists design experiments to char-
acterize better the presence or absence of sex differenc-
es in new phenomena that they are investigating” [1].
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